Representative phenotypic marker characterisation of human, RM, and AGM PBL and DC. Cells were labelled with marker antibodies and analysed by flow cytometry using a BD FACSCalibur. HLA-DR labels activated PBL. Monocyte-derived DC are CD14−CD1a+. MHC class II HLA-DR and co-stimulatory molecule CD80 labelling indicate PBL activation and DC maturation, respectively. * The CD1a antibody did not cross-react with AGM CD1a surface antigen, as previously shown (Mortara et al., 2006) . (B) PBL and DC were isolated and activated/differentiated from rhesus macaque blood. Cells (3 × 10 5 ) were infected in 12-well plates with 100 ng of p24/p27 antigen of SIVmac239-IRES-eGFP, env-defective NL43-IRES-eGFP pseudotyped with VSV-G, or R5-tropic NL43-92th014.12 IRES-eGFP. Infectivity was assessed 3 dpi by flow cytometry. The graph shows triplicate values ± SEM of a representative experiment. (C) Reverse transcription inhibitors were tested for efficiency against different retroviruses. MDTF cells, which lack TRIM5α-mediated restriction, were transduced with the indicated retroviruses at MOI 1 in the presence of antiretroviral drugs. Transduction efficiency was measured at 3 dpt by flow cytometry detection of GFP. Human PBMC lysates were probed for endogenous TRIM5α using a home-made rabbit polyclonal antibody raised against a C-terminal fragment of TRIM5α (Zhang et al., 2008) , comparing it with two commercial antibodies: polyclonal rabbit anti-TRIM5α antibody (IMG-5534) and peptide-affinity purified polyclonal antibody to TRIM5α (IN1; IMG-5588). Samples were run as triplicates on the same gel, and after transfer the membrane was cut in three to probe with each antibody separately. All three membranes were then developed simultaneously on the same radiograph. (B) Human PBL were lipofected with a siRNA against TRIM5α (HM3) and labelled with the rabbit polyclonal anti-TRIM5α antibody followed by anti-rabbit Alexa 488 at 24 h post-transfection. Knockdown efficiency was assessed in parallel by quantitative PCR. (C) MDTF cells were transduced with retroviral vector LPCX encoding human or RM TRIM5α-HA and labelled with anti-HA and anti-TRIM5α antibodies. Scale bars = 10 µm. 
Supplemental Experimental Procedures
Drugs. Ginkgolic acid (GA), iodocetamide (IAA), leptomycin B (LMB), nevirapine (Nev) were obtained from Sigma and Tenofovir (TDF) from Alsachim. Interferon alpha was purchased from R&D Systems (Recombinant Human IFNα2b).
siRNA/shRNA. siRNA directed against human (H) and rhesus macaque (M) TRIM5α, HM1 (GCUCAGGGAGGUCAAGUUG), HM3 (GCACUGUCUCAUUCUUCAA), and non-targeting siLuc control (GCCAUUCUAUCCUCUAGAGGAUG) siRNAs were purchased from Santa Cruz Biotechnology. shRNA against cGAS and LacZ were described previously (Lahaye et al., 2013) .
Antibodies. Primary antibodies were rabbit polyclonal antibody raised against a C-terminal fragment of TRIM5α (Zhang et al., 2008) , mouse monoclonal anti-coilin (Pdelta, Abcam), anti-SUMO1 (21C7, Developmental Studies Hybridoma Bank), anti-PML (PG-M3, Santa Cruz Biotechnology), anti-GM-130 (35/GM130, BD Transduction Laboratories), anti-lamin A/C (636, Leica Biosystems), anti-beta-tubulin (TUB2.1, Sigma), anti-β-actin (AC-74, Sigma) rat monoclonal anti-HA (3F10, Roche), and rabbit polyclonal anti-SUMO2/3 (Invitrogen). Conjugated antibodies were HLA-DR-PE, CD4-APC, CD14-FITC, and CD1a-PE from BD Biosciences, CD80-PE from Caltag and HRPconjugated antibodies from GE Healthcare. Secondary antibodies were anti-rabbit Alexa 488 and anti-mouse Alexa 647 (Invitrogen).
Quantitative RT-PCR. Total RNAs were extracted using RNeasy Mini Kit (Qiagen) and cDNAs prepared using RevertAid H Minus First Strand cDNA Synthesis Kit (Thermo Scientific). Real-time PCR reactions were performed in duplicate using Takyon ROX SYBR Mastermix dTTP blue (Eurogentec) following manufacturer's instructions. Realtime PCR reactions were performed on a 7900HT Fast Real-Time PCR System (Applied Biosystems). Transcripts were quantified using the following program: 3 min at 95°C followed by forty cycles of 15 s at 95°C, 20 s at 60°C and 20 s at 72°C. RPL13A (ribosomal protein L13A) and beta-2-microglobulin (β2M) were used as housekeeping genes to normalize mRNA expression. The ratio of gene of interest versus housekeeping gene was calculated using the 2−ΔΔCt method.
Primers IFN quantification. IFN secretion was quantified using the reporter cell line HL116 that carries the luciferase gene under the control of the IFN-inducible 6-16 promoter (Uze et al., 1994) . HL116 cells (2×10 4 ) were plated in 96-well plates and incubated for 8 h with the DC culture supernatants or a standard of human IFNβ reference . Cells were then lysed (Luciferase Cell Culture Lysis Reagent, Promega) and luciferase activity measured using a luminometer. IFN titers are expressed in international unit/ml relative to the human IFNβ reference (Gb-23-902-531) of the NIH.
